Physician profile
Cecil T Holbert
NPI 1003803891
$10,780.96
in general payments reported to CMS, 2019-2025
42 companies · $1,506 in 2025
The $1,506 reported for 2025 was more than what 92% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,543 · 2020: $981 · 2021: $1,877 · 2022: $1,742 · 2023: $1,751 · 2024: $1,381 · 2025: $1,506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,558 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,558.04 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,592.35 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $1,520.48 | 2019-2025 | |
| Novo Nordisk INC | $1,473.07 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $1,166.57 | 2019-2025 | |
| Astellas Pharma US INC | $659.25 | 2019-2025 | Veozah, Myrbetriq |
| Janssen Pharmaceuticals, INC | $315.58 | 2020-2024 | Spravato |
| Amgen INC. | $310.17 | 2019-2025 | Evenity |
| Bayer Healthcare Pharmaceuticals INC. | $299.45 | 2022-2025 | |
| Exact Sciences Corporation | $273.41 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novartis Pharmaceuticals Corporation | $260.07 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $244.42 | 2020-2025 | Xifaxan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $244.18 | 2019-2024 | Tradjenta, Jardiance |
| Lilly USA, LLC | $241.76 | 2019-2025 | Zepbound, Mounjaro, Trulicity |
| Sunovion Pharmaceuticals INC. | $220.25 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $214.81 | 2019-2022 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cecil Holbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.